Amneal Pharmaceuticals, Inc. (AMRX): Form 8-K filed 2026-08-03
- Accepted by EDGAR
- 2026-08-03 16:28 ET
- Event date
- 2026-08-03
- Accession no.
- 0001628280-26-051900
- Original filing
- SEC EDGAR filing index
Items reported
- Item 1.01: Entry into a Material Definitive Agreement
The company signed a material agreement outside the ordinary course of business, or materially amended one. Typical examples are credit agreements, merger agreements, large supply or licensing contracts and financing arrangements.
Documents
| Type | Description | Document |
|---|---|---|
| 8-K | 8-K | amrx-20260803.htm |
| EX-10.1 | EX-10.1 | a20260803_repricingpacka.htm |
This page lists what the filing reports; it does not summarize or interpret it. Read the original documents on SEC EDGAR. How to read an 8-K.